Bioorg Med Chem Lett. 2011 Oct 1;21(19):5673-9. doi: 10.1016/j.bmcl.2011.07.074. Epub 2011 Jul 27.

Strategies to improve in vivo toxicology outcomes for basic candidate drug molecules.

Luker T, Alcaraz L, Chohan KK, Blomberg N, Brown DS, Butlin RJ, Elebring T, Griffin AM, Guile S, St-Gallay S, Swahn BM, Swallow S, Waring MJ, Wenlock MC, Leeson PD.

Source

AstraZeneca R&D, Medicinal Chemistry, Charnwood, Loughborough, Leicestershire LE11 5RH, UK. Tim.Luker@astrazeneca.com

Abstract

A valid PLS-DA model to predict attrition in pre-clinical toxicology for basic oral candidate drugs was built. A combination of aromatic/aliphatic balance, flatness, charge distribution and size descriptors helped predict the successful progression of compounds through a wide range of toxicity testing. Eighty percent of an independent test set of marketed post-2000 basic drugs could be successfully classified using the model, indicating useful forward predictivity. The themes within this work provide additional guidance for medicinal design chemists and complement other literature property guidelines.

PMID:: 21852131; [PubMed - indexed for MEDLINE]

MeSH Terms, Substances

MeSH Terms

Substances

Pharmaceutical Preparations

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Miscellaneous

See the articles recommended by F1000Prime's Faculty of 5,000 renowned researchers and clinicians, assisted by 5,000 associates. - F1000

Supplemental Content

Save items

Related citations in PubMed

High dose selection in general toxicity studies for drug development: A pharmaceutical industry perspective. [Regul Toxicol Pharmacol. 2009]
High dose selection in general toxicity studies for drug development: A pharmaceutical industry perspective.
Buckley LA, Dorato MA. Regul Toxicol Pharmacol. 2009 Aug; 54(3):301-7. Epub 2009 May 27.
Molecular clinical safety intelligence: a system for bridging clinically focused safety knowledge to early-stage drug discovery - the GSK experience. [Drug Discov Today. 2011]
Molecular clinical safety intelligence: a system for bridging clinically focused safety knowledge to early-stage drug discovery - the GSK experience.
Vanderwall DE, Yuen N, Al-Ansari M, Bailey J, Fram D, Green DV, Pickett S, Vitulli G, Luengo JI, Almenoff JS. Drug Discov Today. 2011 Aug; 16(15-16):646-53. Epub 2011 May 11.
Review Computational toxicology--a tool for early safety evaluation. [Drug Discov Today. 2010]
Review Computational toxicology--a tool for early safety evaluation.
Merlot C. Drug Discov Today. 2010 Jan; 15(1-2):16-22. Epub 2009 Oct 14.
Review [Strategy of molecular drug design: hits, leads and drug candidates]. [Yao Xue Xue Bao. 2008]
Review [Strategy of molecular drug design: hits, leads and drug candidates].
Guo ZR. Yao Xue Xue Bao. 2008 Sep; 43(9):898-904.
Review Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety. [Chem Res Toxicol. 2011]
Review Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety.
Meanwell NA. Chem Res Toxicol. 2011 Sep 19; 24(9):1420-56. Epub 2011 Jul 26.

See reviews... See all...

Cited by 1 PubMed Central article

Quantifying the chemical beauty of drugs. [Nat Chem. 2012]
Quantifying the chemical beauty of drugs.
Bickerton GR, Paolini GV, Besnard J, Muresan S, Hopkins AL. Nat Chem. 2012 Jan 24; 4(2):90-8. Epub 2012 Jan 24.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Strategies to improve in vivo toxicology outcomes for basic candidate drug molec...
Strategies to improve in vivo toxicology outcomes for basic candidate drug molecules.
Bioorg Med Chem Lett. 2011 Oct 1 ;21(19):5673-9. doi: 10.1016/j.bmcl.2011.07.074. Epub 2011 Jul 27 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: